Ultrasound (US) Guided External Ventricular Catheter Placement
- Conditions
- Hydrocephalus
- Interventions
- Device: Catheter Placement with Solopass System
- Registration Number
- NCT06253858
- Lead Sponsor
- Milton S. Hershey Medical Center
- Brief Summary
To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 10
- Decision made to perform the procedure by the primary consultant
- Age 18 or older
- Neuro ICU stay
- Newly diagnosed hydrocephalus
- Has a recent CT within the past 24 hrs
- Normal platelets and coagulation profile
- No active infection or currently on antibiotics
- The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging
- Age <18
- Not in Neuro ICU setting
- Previous placement of a ventricular catheter
- More than 50 percent of the fluid compartment is filled with blood by CT scan
- Time to include in the trial prohibited by clinical personnel
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Catheter placement with Solopass system Catheter Placement with Solopass System The Solopass US system will be used during catheter placement procedure to guide the placement of the catheter.
- Primary Outcome Measures
Name Time Method Average number of passes needed to place the catheter in each subject. 0 minutes Measured by the number of passes needed to place the catheter. If the first attempt fails, another US sweep will be performed, and another attempt will be performed. If that fails, then the procedure will be aborted.
- Secondary Outcome Measures
Name Time Method Post procedure imaging accuracy of the placement of the EVD will be performed by reviewing post procedure imaging using the Kakarla scoring system up to 7 days Grade 1 means optimal placement in the ipsilateral frontal horn or third ventricle; Grade 2 means a functional placement in the contralateral lateral ventricle or no eloquent cortex; and Grade 3 means suboptimal placement in the eloquent cortex or nontarget cerebrospinal fluid space, with or without functional drainage